VTRS - Regeneron gains after win in patent suit over Eylea vs Viatris
2023-12-27 13:33:38 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference (Transcript)
- Regeneron lymphoma therapy shows high response rate in ongoing trial
- Regeneron lifts complete remission in trial for multiple myeloma candidate
For further details see:
Regeneron gains after win in patent suit over Eylea vs Viatris